US Patent Issued to SUNSHINE LAKE PHARMA on March 25 for "Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,317, issued on March 25, was assigned to SUNSHINE LAKE PHARMA Co. LTD. (Dongguan, China).

"Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof" was invented by Zheng Gu (Dongguan, China), Jianhao Li (Dongguan, China), Weihua Wang (Dongguan, China), Haoxiong Qin (Dongguan, China) and Xinshan Deng (Dongguan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An isoquinolinone compound acts as an inhibitor of semicarbazide-sensitive oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1), and the use thereof, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition c...